Regeneron Signs Sanofi To Potential $1B Collaboration Nov. 30, 2007 By Donna Young Regeneron Pharmaceuticals Inc. and Sanofi-Aventis are collaborating to discover, develop and commercialize human therapeutic antibodies in a cash and stock deal potentially worth $1 billion. (BioWorld Today)Read More
RSS